NeueHealth (NYSE:NEUE – Get Free Report) is one of 14 publicly-traded companies in the “Hospital & medical service plans” industry, but how does it contrast to its rivals? We will compare NeueHealth to similar businesses based on the strength of its dividends, analyst recommendations, valuation, profitability, risk, earnings and institutional ownership.
Earnings & Valuation
This table compares NeueHealth and its rivals top-line revenue, earnings per share and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
NeueHealth | $1.16 billion | -$1.15 billion | -0.04 |
NeueHealth Competitors | $80.60 billion | $2.78 billion | 9.22 |
NeueHealth’s rivals have higher revenue and earnings than NeueHealth. NeueHealth is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Profitability
Net Margins | Return on Equity | Return on Assets | |
NeueHealth | -71.23% | N/A | -1.21% |
NeueHealth Competitors | -0.07% | -1.85% | 0.08% |
Institutional and Insider Ownership
63.9% of NeueHealth shares are held by institutional investors. Comparatively, 80.4% of shares of all “Hospital & medical service plans” companies are held by institutional investors. 64.3% of NeueHealth shares are held by insiders. Comparatively, 10.2% of shares of all “Hospital & medical service plans” companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Risk & Volatility
NeueHealth has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500. Comparatively, NeueHealth’s rivals have a beta of 0.95, suggesting that their average stock price is 5% less volatile than the S&P 500.
Analyst Ratings
This is a summary of current recommendations and price targets for NeueHealth and its rivals, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
NeueHealth | 0 | 1 | 0 | 0 | 2.00 |
NeueHealth Competitors | 94 | 1125 | 2574 | 99 | 2.69 |
NeueHealth currently has a consensus price target of $8.00, indicating a potential upside of 28.00%. As a group, “Hospital & medical service plans” companies have a potential upside of 15.77%. Given NeueHealth’s higher probable upside, research analysts plainly believe NeueHealth is more favorable than its rivals.
Summary
NeueHealth rivals beat NeueHealth on 10 of the 13 factors compared.
About NeueHealth
NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.